Cargando…
Risk factors associated with nasopharyngeal carriage and density of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in young children living in Indonesia
BACKGROUND: Potentially pathogenic bacteria Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus are commonly carried in the nasopharynx of young children. Host and environmental factors have been linked with pathogen carriage, and in many studies rural...
Autores principales: | Fadlyana, Eddy, Dunne, Eileen M., Rusmil, Kusnandi, Tarigan, Rodman, Sudigdoadi, Sunaryati, Murad, Chrysanti, Watts, Emma, Nguyen, Cattram, Satzke, Catherine, Dewi, Nurhandini Eka, Indriyani, Sang Ayu Kompiyang, Yani, Finny Fitry, Mulholland, Kim, Kartasasmita, Cissy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305570/ https://www.ncbi.nlm.nih.gov/pubmed/30603377 http://dx.doi.org/10.1186/s41479-018-0058-1 |
Ejemplares similares
-
Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: A cross-sectional study
por: Dunne, Eileen M., et al.
Publicado: (2018) -
Correlation Between Vitamin D Status and HBsAg Antibody Levels in Indonesian Adolescents Immunised Against Hepatitis B
por: Girsang, Rodman Tarigan, et al.
Publicado: (2023) -
Comparison of Immunogenicity and Safety of Diphtheria–Tetanus–Pertussis–Hepatitis B–Haemophilus influenza B (Bio Farma) with Pentabio(®) Vaccine Primed with Recombinant Hepatitis B at Birth (Using Different Source of Hepatitis B) in Indonesian Infants
por: Fadlyana, Eddy, et al.
Publicado: (2023) -
Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults
por: Fadlyana, Eddy, et al.
Publicado: (2023) -
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia
por: Fadlyana, Eddy, et al.
Publicado: (2021)